Skip to main content

Table 1 Summary of magnetic resonance imaging results for tumor volume, longitudinal relaxivity, blood volume and passive permeability

From: Vascular endothelial growth factor blockade alters magnetic resonance imaging biomarkers of vascular function and decreases barrier permeability in a rat model of lung cancer brain metastasis

 

Saline control

Bevacizumab treatment

 

Pre

Post

Pre

Post

Tumor volume, range (mm3)

7.34–36.9

9.20–58.2

6.96–46.8

8.13–44.5

Tumor volume, mean ± sd (mm3)

14.7 ± 9.4

22.7 ± 15.7

16.1 ± 13.2

17.8 ± 12.3

R1, range (ms–1)

0.45–0.54

0.42–0.55

0.45–0.57

0.49–0.59

R1, mean ± sd (ms–1)

0.53 ± 0.03

0.50 ± 0.04

0.53 ± 0.04

0.54 ± 0.04

Steady-state rCBV, range

0.76–2.89

0.63–1.63

0.92–1.61

0.63–1.55

Steady-state rCBV, mean ± sd

1.45 ± 0.83

1.17 ± 0.45

1.20 ± 0.26

0.93 ± 0.26

Ktrans, range (min–1)

0.027–0.084

0.026–0.084

0.016–0.064

0.014–0.054

Ktrans, mean ± sd (min–1)

0.047 ± 0.018

0.056 ± 0.018

0.043 ± 0.016

0.031 ± 0.014

  1. R1: longitudinal relaxivity, rCBV: relative cerebral blood volume, Ktrans: vascular transfer coefficient.